ALNYLAM PHARMACEUTICALS, INC. EPS (Basic) 2009-2025 | ALNY
Beta
What is eps (basic)?
Basic earnings per share (EPS) can be defined as net income divided by the weighted average number of common shares outstanding during a period.
What is ALNYLAM PHARMACEUTICALS, INC.'s current eps (basic)?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual eps (basic) for 2025 was $2.39, a 209.63% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. eps (basic) for the quarter ending September 30, 2025 was $1.91.
What was ALNYLAM PHARMACEUTICALS, INC.'s eps (basic) in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual eps (basic) for 2024 was $-2.18, a 38.07% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s eps (basic) in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual eps (basic) for 2023 was $-3.52, a 62.15% increase from 2022.
EPS (Basic) History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGRN/A
FY2020
$-7.46
→
FY2025
$2.39
0910111213141516171819202122232425
5 years selected
EPS (Basic) History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.39 | +209.6% | 10-K |
| FY2024 | $-2.18 | +38.1% | 10-K |
| FY2023 | $-3.52 | +62.2% | 10-K |
| FY2022 | $-9.30 | -29.2% | 10-K |
| FY2021 | $-7.20 | +3.5% | 10-K |
| FY2020 | $-7.46 | +8.0% | 10-K |
| FY2019 | $-8.11 | -7.1% | 10-K |
| FY2018 | $-7.57 | -39.7% | 10-K |
| FY2017 | $-5.42 | -13.2% | 10-K |
| FY2016 | $-4.79 | -38.8% | 10-K |
| FY2015 | $-3.45 | +28.9% | 10-K |
| FY2014 | $-4.85 | -234.5% | 10-K |
| FY2013 | $-1.45 | +31.3% | 10-K |
| FY2012 | $-2.11 | -55.1% | 10-K |
| FY2011 | $-1.36 | -30.8% | 10-K |
| FY2010 | $-1.04 | +8.8% | 10-K |
| FY2009 | $-1.14 | - | 10-K |
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →